Table 1. Patient demographics and management characteristics.

Age and sex are presented for each case in addition to diagnosis type, maximum IOP (IOPmax), central corneal thickness (CCT), treated IOP (most recent IOP), treatment, follow-up duration, and progression features.

Case	Sex	Age	Diagnosis	IOPmax	CCT	Most Recent IOP	Treatment	Follow-up (Months)	Progression
1	M	41	OAG	Right – 29	595	14	IOP lowering drops bilaterally	10	Initial progression. No progression post final IOP lowering treatment either eye.
				Left – 26	583	16
2	F	32	OHT	Right – 27	611	25	Observation	30	No progression either eye.
				Left – 27	608	25
3	M	83	OAG	Right – 28	543	12	Right – SLT x1 with 3 IOP lowering drops.	54	Initial progression. No progression post final IOP lowering treatment either eye.
				Left – 28	553	9	Left – SLT x1 and IOP lowering drops followed by Trabeculectomy
4	F	78	PXE	Right – 34	574	22	Right – 3 IOP lowering medications and SLT.	118	Initial progression. No progression post final IOP lowering treatment either eye.
				Left – 24	587	18	Left – 1 IOP lowering drop initiated later in course.
5	F	69	OAG	Right – 32	520	10	Right – IOP lowering drops and SLT followed by trabeculectomy.	21	Initial progression. No progression post final IOP lowering treatment either eye.
				Left – 35	518	13	Left – IOP lowering drops and SLT followed by trabeculectomy.
6	F	44	PD	Right – 25	613	18	IOP lowering drops bilaterally	11	No progression either eye.
				Left – 25	600	15

Abbreviations: M = male, F = female, IOPmax = maximum intraocular pressure, CCT = central corneal thickness, IOP = intraocular pressure, SLT = selective laser trabeculoplasty, OAG = open angle glaucoma, OHT = ocular hypertension, PXE = pseudoexfoliation glaucoma, PD = pigment dispersion glaucoma